Skip to main content

Neurofibromatosis News

Related terms: NF, Neurofibromatosis-1, Neurofibromatosis 2, NF1, Von Recklinghausen neurofibromatosis, NF2, Bilateral acoustic neurofibromatosis, Central bilateral acoustic NF

FDA Approves Gomekli (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

STAMFORD, Conn., Feb. 11, 2025 – SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the U.S....

FDA Approves Koselugo (selumetinib) for Pediatric Patients with Neurofibromatosis Type 1 Plexiform Neurofibromas

13 April 2020 – AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved...

Ask a question

To post your own question to our community, sign in or create an account.